• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK SJM TRIFECTA VALVE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Renal Failure (2041); Transient Ischemic Attack (2109)
Event Date 01/01/2013
Event Type  Injury  
Manufacturer Narrative
B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided.The additional patient effect of malfunction reported in the article is captured under a separate medwatch report.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
The article, "minimally invasive surgical aortic valve replacement versus transfemoral transcatheter aortic valve implantation in low-risk octogenarians", was reviewed.The article presented a retrospective, single center study on low-risk (society of thoracic surgeons [sts] score<4%) octogenarians before and after transfemoral transcatheter aortic valve implantation (tf-tavi) and minimally invasive aortic valve replacement (mini-avr) performed between (b)(6) 2013 and (b)(6) 2019; follow-up was completed in (b)(6) 2022.Devices included in this study were sapien 3/xt, evolut r, portico, trifecta, enable, perceval, intuity, and other unknown.The article concluded that in the present study on low-risk octogenarians, transfemoral tavi and minimally invasive avr showed comparable short-term and mid-term results.Both procedures are deemed safe and effective.Larger randomized controlled trials will be required to determine which low risk patients will benefit most from tavi.[(b)(6)].The time frame of the study was from (b)(6) 2013 to (b)(6) 2019.A total of 301 patients were included in this study, of which 20 received an abbott device.The average age was 83.8 years and the average gender was female.Comorbidities included arterial hypertension, diabetes mellitus, coronary artery disease, prior myocardial infarction, peripheral vascular disease, syncope, atrial fibrillation, pulmonary hypertension, chronic pulmonary disease, prior stroke, prior transient ischemic attack, and tumor.
 
Manufacturer Narrative
Summarized patient outcomes/complications of trifecta valve were reported in a research article in a subject population with multiple co-morbidities including arterial hypertension, diabetes mellitus, coronary artery disease, prior myocardial infarction, peripheral vascular disease, syncope, atrial fibrillation, pulmonary hypertension, chronic pulmonary disease, prior stroke, prior transient ischemic attack, and tumor.Some of the complications reported were acute kidney injury, new onset atrial fibrillation, permanent pacemaker implant, stroke, transient ischemic attack, bleeding, and paravalvular leak.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature attachment: article title " minimally invasive surgical aortic valve replacement versus transfemoral transcatheter aortic valve implantation in low-risk octogenarians".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18519577
MDR Text Key332974640
Report Number2135147-2024-00255
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeSI
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SJM TRIFECTA VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Required Intervention; Life Threatening;
-
-